Cornerstone Wealth Group LLC lifted its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,179 shares of the conglomerate’s stock after acquiring an additional 98 shares during the quarter. Cornerstone Wealth Group LLC’s holdings in Danaher were worth $271,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Decker Retirement Planning Inc. bought a new position in shares of Danaher in the fourth quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America purchased a new stake in Danaher in the 3rd quarter worth $39,000. MidAtlantic Capital Management Inc. bought a new stake in Danaher during the third quarter valued at about $40,000. FSA Wealth Management LLC purchased a new position in shares of Danaher in the third quarter valued at about $50,000. Finally, Darwin Wealth Management LLC purchased a new stake in shares of Danaher during the third quarter worth about $55,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently commented on DHR shares. Stifel Nicolaus boosted their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Robert W. Baird lowered their target price on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Barclays dropped their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Finally, Scotiabank started coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $285.55.
Danaher Stock Up 1.9 %
Shares of NYSE DHR opened at $250.51 on Tuesday. Danaher Co. has a 1 year low of $225.42 and a 1 year high of $281.70. The firm has a 50-day simple moving average of $235.33 and a two-hundred day simple moving average of $253.62. The company has a market cap of $180.94 billion, a P/E ratio of 47.81, a PEG ratio of 4.43 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio is currently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Sizing Up a New Opportunity for NVIDIA Investors
- The 3 Best Blue-Chip Stocks to Buy Now
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- What is the MACD Indicator and How to Use it in Your Trading
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.